CME Group (NASDAQ:CME) posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.42 by $0.03, MarketWatch Earnings reports. The business had revenue of $904.20 million during the quarter, compared to analysts’ expectations of $910.50 million. CME Group had a net margin of 113.67% and a return on equity of 9.18%.
Shares of CME traded up $0.31 during mid-day trading on Friday, hitting $189.74. 2,459,969 shares of the company’s stock were exchanged, compared to its average volume of 2,184,394. CME Group has a twelve month low of $137.51 and a twelve month high of $190.43. The firm has a market cap of $64.06 billion, a price-to-earnings ratio of 39.78, a price-to-earnings-growth ratio of 2.19 and a beta of 0.49. The company has a quick ratio of 1.08, a current ratio of 1.09 and a debt-to-equity ratio of 0.15.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 27th. Stockholders of record on Monday, December 10th will be paid a dividend of $0.70 per share. The ex-dividend date is Friday, December 7th. This represents a $2.80 annualized dividend and a dividend yield of 1.48%. CME Group’s dividend payout ratio (DPR) is 58.70%.
CME has been the subject of a number of research reports. Zacks Investment Research upgraded shares of CME Group from a “sell” rating to a “hold” rating in a report on Wednesday, October 3rd. Bank of America restated a “buy” rating and issued a $200.00 price target on shares of CME Group in a research report on Monday, November 5th. Jefferies Financial Group upped their price target on shares of CME Group to $203.00 and gave the company a “buy” rating in a research report on Monday, October 8th. BidaskClub upgraded shares of CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, October 9th. Finally, Rosenblatt Securities started coverage on shares of CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 price target for the company. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and one has given a strong buy rating to the company. CME Group currently has an average rating of “Buy” and an average target price of $182.69.
CME Group Company Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
Read More: Compound Annual Growth Rate (CAGR)
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.